Clinical trial
Phase 1 Thorough QT Study in Young Healthy Volunteers
NCT00485667 · Pacira Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT00485667 |
|---|---|
| Title | Phase 1 Thorough QT Study in Young Healthy Volunteers |
| Official title | Evaluation of the Effects of Therapeutic and Supra-therapeutic Single Doses of SKY0402 Given as Subcutaneous Injection on the QT/QTc Interval in Young Healthy Volunteers. A Prospective, Randomized, Placebo- and Positive-controlled, Double Blind, Single-centre, Crossover Phase 1 Study. |
| Acronym | TQT |
| Lead sponsor | Pacira Pharmaceuticals, Inc, Industry |
| Collaborators | Richmond Pharmacology Limited Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Postoperative Pain |
| Intervention type | Drug |
| Interventions | SKY0402, Moxifloxacin 400mg, Placebo injection, Placebo tablet |
| Enrollment | 48 |
| Start date | Jun 1, 2007 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jun 13, 2007 |
| Last update posted | Feb 16, 2021 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: